Breaking News, Collaborations & Alliances

Lonza, Intellect Neurosciences in ADC Pact

To supply preclinical materials for drug optimization

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Intellect Neurosciences has selected Lonza for the future development and manufacture of its antibody-drug conjugate CONJUMAB-A, subject to completing a definitive agreement. Lonza will supply the preclinical study material for the drug optimization and drug selection for Intellect’s CONJUMAB-A, initially focusing on age-related macular degeneration (AMD), with potential applications for Alzheimer’s disease.   The program will include in vitro and in vivo studies to evaluate both the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters